or Try an Advanced Search...

    Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    B 16.38 -0.18% -0.03
    DAWN closed down 0.18 percent on Thursday, May 9, 2024, on 55 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical DAWN trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Earnings Movers Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -0.18%
    Gapped Down Weakness -0.18%
    Outside Day Range Expansion -4.10%
    Wide Bands Range Expansion -4.10%
    Overbought Stochastic Strength -4.10%
    NR7 Range Contraction -1.33%
    Older End-of-Day Signals for DAWN ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 19 hours ago
    10 DMA Resistance about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Up 3% about 22 hours ago
    Rose Above 10 DMA about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DAWN Chart by TradingView
    Basic chart:

    Profile

    Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Enzymes Protein Kinase Inhibitor Signal Transduction Protein Kinase Kinase Ym Biosciences

    Is DAWN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 6 Day One Biopharmaceuticals GAAP EPS of -$0.72 misses by $0.06
    May 6 Day One Reports First Quarter 2024 Financial Results and Corporate Progress
    May 4 Insider Sale at Day One Biopharmaceuticals Inc (DAWN)
    Apr 24 Day One slips despite Ojemda approval as BofA says label “not a home run”
    Apr 24 Day One Pharmaceuticals: Ojemda Approval A Big Win, Current Valuation Fair
    Apr 23 Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
    Apr 23 Day One wins FDA nod for brain cancer therapy, Ojemda
    Mar 15 Companies Like Day One Biopharmaceuticals (NASDAQ:DAWN) Are In A Position To Invest In Growth
    Mar 13 13 Best Biotech Stocks To Buy Under $20
    Feb 28 Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results
    See more DAWN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.0699
    52 Week Low 9.67
    Average Volume 1,235,899
    200-Day Moving Average 13.79
    50-Day Moving Average 15.45
    20-Day Moving Average 15.78
    10-Day Moving Average 16.74
    Average True Range 1.12
    RSI (14) 53.05
    ADX 24.94
    +DI 28.41
    -DI 15.76
    Chandelier Exit (Long, 3 ATRs) 14.71
    Chandelier Exit (Short, 3 ATRs) 16.38
    Upper Bollinger Bands 18.37
    Lower Bollinger Band 13.20
    Percent B (%b) 0.62
    BandWidth 32.76
    MACD Line 0.49
    MACD Signal Line 0.42
    MACD Histogram 0.0747
    Fundamentals Value
    Market Cap 1.43 Billion
    Num Shares 87 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -7.15
    Price-to-Sales 0.00
    Price-to-Book 3.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 17.40
    Resistance 3 (R3) 17.47 17.21 17.23
    Resistance 2 (R2) 17.21 16.95 17.17 17.17
    Resistance 1 (R1) 16.79 16.79 16.66 16.72 17.12
    Pivot Point 16.53 16.53 16.46 16.49 16.53
    Support 1 (S1) 16.11 16.27 15.98 16.04 15.64
    Support 2 (S2) 15.85 16.11 15.81 15.59
    Support 3 (S3) 15.43 15.85 15.53
    Support 4 (S4) 15.36